Hypothesis: additional cytogenetic abnormalities and progression to acute phase in chronic myelogenous leukemia
Aurer, I.; Canaani, E.; Gale, R.P.
Leukemia 5(11): 1012-1013
1991
ISSN/ISBN: 0887-6924 PMID: 1961031 Document Number: 369863
Document emailed within 1 workday
Related Documents
Lai, J.L.; Fenaux, P.; Zandecki, M.; Nelken, B.; Huart, J.J.; Deminatti, M. 1989: Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities Annales de Genetique 32(1): 26-32Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Lisker, R.; Pérez-Chávez, F.; Casas, L.; Córdova, M.S.; Mutchinick, O. 1980: Chronic myelogenous leukemia. Correlation between clinical, laboratory and cytogenetic data Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 32(2): 187-192
Karnolsky, I.N. 2000: Cytogenetic abnormalities in chronic lymphocytic leukemia Folia Medica 42(3): 5-10
Eaves, A.C.; Eaves, C.J. 1979: Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML) Experimental Hematology 7(Suppl 5): 65-75
Guilhot, F. 1994: The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S39-S46
Anastasi, J.; Feng, J.; Le Beau, M.M.; Larson, R.A.; Rowley, J.D.; Vardiman, J.W. 1995: The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia Leukemia 9(4): 628-633
Ishibashi, T.; Abe, R.; Kimura, H.; Shichishima, T.; Matsuda, S.; Uchida, T.; Kariyone, S. 1985: Involvement of eosinophils in leukemic clones: cytogenetic study in eosinophilic colonies from acute myelogenous leukemia associated with 8;21 translocation Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(5): 1161-1167
Usman, M.; Kakepoto, G.N.; Adil, S.N.; Sajid, R.; Arain, S.; Khurshid, M. 2004: Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a tertiary care hospital Jpma. Journal of the Pakistan Medical Association 54(1): 17-20
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Izumiguchi, Y.; Iwanaga, Y.; Nasu, M.; Sato, T.; Fujita, S.; Kai, S.; Krosaki, M.; Hara, H. 1979: Morphological changes of megakaryocytes in acute myelogenous leukemia and preleukemic phase Rinsho Byori. Japanese Journal of Clinical Pathology 27(1): 73-76
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Lozyns'ka, M.P.; Masliak, Z.V.; Lukavets'kyĭ, L.M.; Tsiapka, O.M.; Lozyns'kyĭ, R.I. 2005: Prognostic significance of additional chromosomal abnormalities in Ph positive bone marrow cells in chronic myeloid leukemia Tsitologiia i Genetika 39(1): 26-33
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Decker, R.W.; Ho, W.G.; Champlin, R.E. 1987: Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia Cancer Treatment Reports 71(9): 881-882
Vogler, W.R.; Velez-Garcia, E.; Omura, G.; Raney, M. 1989: A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia Seminars in Oncology 16(1 Suppl 2: 21-24
Nawata, R.; Shinohara, K.; Yamada, T.; Takahashi, T.; Katsuki, K.; Takeda, K.; Kameda, N.; Ariyoshi, K.; Ota, I.; Muraki, K. 2000: Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses International Journal of Hematology 71(4): 353-358
Takaku, F. 1978: Acute lymphoblastic transformation in chronic myelogenous leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1622-1623